What the Latest Johnson & Johnson COVID-19 Vaccine Trial Data Really Means | Johnson & Johnson
Coronavirus: Description video
Watch the video “What the Latest Johnson & Johnson COVID-19 Vaccine Trial Data Really Means | Johnson & Johnson” and like it!
Lisa Ling kicks off the season 3 premier of “The Road to a Vaccine” by speaking with Johnson & Johnson Chief Scientific Officer Dr. Paul Stoffels, whose team was pivotal in the development of the company’s COVID-19 vaccine candidate. See what he has to say following Johnson & Johnson’s announcement of phase 3 vaccine clinical trial results.
Also tune in to hear from scientific experts like Harvard’s Dr. Dan Barouch as he and others discuss the latest on where we are in the in the fight against COVID-19 and what’s next for vaccine development. Plus, hear other news and updates about the coronavirus pandemic with Dr. Uché Blackstock.
Be sure to tune in for the next live episode of Johnson & Johnson’s weekly live web series, “The Road to a Vaccine," which airs on Tuesdays at 12:00 PM ET.
Subscribe to J&J on YouTube and keep up-to-date with the latest episodes:
Connect with Johnson & Johnson on social media:
J&J on Facebook: http://www.facebook.com/jnj
J&J News on Twitter: https://twitter.com/jnjnews
J&J on LinkedIn: https://www.linkedin.com/company/johnson-&-johnson/
Find updates and news about J&J, including the company’s ongoing work on a potential COVID-19 vaccine, here:
Liked the “What the Latest Johnson & Johnson COVID-19 Vaccine Trial Data Really Means | Johnson & Johnson” video?
Share it with your friends!